venBio Global Strategic Fund III, L.P. - 31 Mar 2025 SCHEDULE 13G/A Report for Artiva Biotherapeutics, Inc. Common Stock, $0.0001 par value per share (ARTV)

Filing Manager
venBio Global Strategic Fund III, L.P.
Reporting Manager
venBio Global Strategic Fund III, L.P.
Security
Artiva Biotherapeutics, Inc. Common Stock, $0.0001 par value per share
Symbol
ARTV
Shares outstanding
24,468,878 shares
Disclosed Ownership
1,198,975 shares
Ownership
4.9%
Form type
SCHEDULE 13G/A
Filing time
15 May 2025, 16:44:26 UTC
Date of event
31 Mar 2025
SEC
View on sec.gov

Reporting Managers (5)

Name Ownership Shares Owned sole voting power shared voting power Signature Title CIK
venBio Global Strategic Fund III, L.P. 4.9% 1,198,975 0 1,198,975 /s/ David Pezeshki David Pezeshki, as attorney-in-fact for Corey Goodman and Robert Adelman, Directors of the General Partner of the General Partner
VENBIO GLOBAL STRATEGIC GP III, L.P. 4.9% 1,198,975 0 1,198,975 /s/ David Pezeshki David Pezeshki, as attorney-in-fact for Corey Goodman and Robert Adelman, Directors of the General Partner
VENBIO GLOBAL STRATEGIC GP III, LTD 4.9% 1,198,975 0 1,198,975 /s/ David Pezeshki David Pezeshki, as attorney-in-fact for Corey Goodman and Robert Adelman, Directors
Adelman Robert J 4.9% 1,198,975 0 1,198,975 /s/ David Pezeshki David Pezeshki, as attorney-in-fact
GOODMAN COREY S 4.9% 1,198,975 0 1,198,975 /s/ David Pezeshki David Pezeshki, as attorney-in-fact